November 7, 2024
Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and related metabolic disorders, presented data from two studies at the annual meeting of The Obesity Society in San Antonio.
Adipo Therapeutics presents positive study results about potential obesity treatment
November 7, 2024
Adipo Therapeutics LLC, a late-stage, preclinical biopharmaceutical company developing a potential treatment for obesity and related metabolic disorders, presented data from two studies at the annual meeting of The Obesity Society in San Antonio.
Adipo Therapeutics presents positive study results about potential obesity treatment
November 6, 2024
Desorption electrospray ionization (DESI) tandem mass spectrometry (MS) is used to assess mutation status of isocitrate dehydrogenase (IDH) in human gliomas. Due to the diffuse nature of gliomas, total gross resection is not normally achieved during surgery, leading to tumor recurrence.
Detection of IDH mutation in glioma by desorption electrospray ionization (DESI) tandem mass spectrometry
November 4, 2024
Correction to: Scientific Reports https://doi.org/10.1038/srep44239, published online 13 March 2017
Author Correction: Myricitrin Alleviates Oxidative Stress-induced Inflammation and Apoptosis and Protects Mice against Diabetic Cardiomyopathy
October 30, 2024
Imagine a hidden world beneath our feet, filled with tiny fungi that form a big network, kind of like the internet for plants. This network is super important because it helps plants get the food they need. Abhiram Sripat, a scientist who started Florence Quantum Labs, has been looking into this secret fungal world.
October 29, 2024
Using a highly promising approach to speed breast cancer diagnostics, researcher W. Andy Tao of the Purdue Institute for Cancer Research is studying how specific blood particles could be used to catch BRCA-related breast cancer before any tumor growth.
WGHI-supported research could lead to blood tests for early breast cancer diagnoses
October 25, 2024
Chronic prostate inflammation in patients with benign prostate hyperplasia (BPH) correlates with the severity of symptoms.
Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist
October 23, 2024
Purdue University recently hosted the DigiTwin 2024 conference, bringing together experts to explore the latest developments in digital twin technologies—virtual models designed to simulate and optimize real-world systems.
Purdue hosts DigiTwin 2024, explores digital twin tech for sustainable manufacturing, resilience
October 16, 2024
As data from the Centers for Disease Control and Prevention reports declining combustible cigarette use, vaping and e-cigarette sales have continued to soar, increasing by more than 46% from January 2020 to December 2022, according to the Truth Initiative. While combustible cigarettes have a proven risk of cancers and other diseases, less is known about the health effects of vaping and e-cigarette use.
Purdue researchers investigate the effects of vaping on oral and lung health
October 16, 2024
Scaling up excellence in the semiconductor and microelectronics industry is a key commitment at Purdue University.
Securing a strong future for microchips: Semiconductors at Purdue
